Skip to main content
. 2017 Jun;10(4):202–210.

Table 2.

Allowed Per-Patient Per-Month Cost of CKD

CKD severity stage Medicare allowed PPPM cost, $ Commercial allowed PPPM cost, $
with hyperkalemia without hyperkalemia with hyperkalemia without hyperkalemia
Stage I 4896 1509 5544 1508
Stage II 4571 1513 6052 1696
Stage III 4552 1842 6658 2488
Stage IV 5043 2525 6843 3703
Stage V 5491 2819 6442 3392
Unknown stage 5803 2450 11,332 3395
All patients with CKDa 4945 2137 7247 2879
a

PPPM cost in the hyperkalemia and nonhyperkalemia populations after adjusting for CKD severity.

CKD indicates chronic kidney disease; PPPM, per-patient per-month.

Source: Milliman's analysis of 2014 Medicare 5% sample data and MarketScan medical claims data.